Wereport an Rh(D)-negative man with myelodysplastic syndrome who produced six anti-erythrocyte alloantibodies (anti-D, -C, -E, -Dia, -Jka and -S) in succession. Three of these antibodies (anti-E, -Jka and -S) were not noted until delayed hemolytic transfusion reactions occurred. Treatment with cortico-steroids was effective in preventing both further formations of antibodies and other transfusion reactions. It was very difficult to find blood compatible with the patient, but repetitive blood transfusions were required for his progressive anemia and thrombocytopenia. Several problems concerning the transfusion of blood in such a case are discussed.
The incidence of anti-erythrocyte antibody formation among patients (excluding pregnant women) with various disorders, is about 1%, and most of the antibodies involved are usually less than three kinds in any single patient (1) . Only once in a while are cases reported wheremore than four antibodies have developed in a single patient (2 -5) .
We report here an unusual case of Rh(D)-negative man with myelodysplastic syndrome who produced six anti-erythrocyte alloantibodies (anti-D, -C, -E, -Dia, -Jka and -S). Several difficult problems when giving blood transfusions to Rh(D)-negative patients who have multiple alloantibodies are also discussed.
CASE REPORT
A 58-year-old Japanese man was admitted to our hospital because of low grade fever and palpitation on April 5, 1988 . He had had several episodes of allergic reactions to antibiotics and analgesic drugs. He had undergone an operation for early gastric cancer on June 25, 1984. During the operation he received a transfusion of three units of Group A, Rh(D)-negative red blood cells. Both screening tests for irregular antierythrocyte antibodies and crossmatching tests were negative, and post-transfusion reactions were not observed at this time. Anti-cancer chemotherapy had not been performed following the operation. Thereafter, he was well until four months before entry.
At the physical examination on admission he was pale. Tachycardia and systolic heart murmur were also noted. Lymphadenopathy, hepatosplenomegaly, and hemorrhagic diathesis were not observed.
vitamin B12 363 pg/ml, the folic acid 4.9 ng/ml, and the erythropoietin 597 mU/ml. The clinical course of this patient is shown in However, on April 12, hemolytic transfusion reactions occurred, which were successfully treated with a bolus of methylprednisolone. On April ll, another alloantibody (anti-E) was detected in his serum. Furthermore, on April 16, two kinds of alloantibodies (anti-Jka and -S) were detected in his serum in addition to the four antibodies being previously discovered.
He was treated with vitamin D3, vitamin A, and anabolic steroids for myelodysplastic syndrome.
However,these treatments were not effective, and repetitive blood transfusions were required because of both his progressive anemia and his thrombocytopenia. All the six antibodies in our patient seem to have been formed as a consequence of a blood transfusion during an operation about four years ago, and to be present in his serum on admission. The reason whyanti-D was detected in the patient, even in the absence of exposure to D antigen, can be explained by the presence of anti-G (10). Almost all red blood cells carrying D, and all cells carrying C, also carry an antigen G. This patient was probably immunized with C-positive cells transfused at the time of the operation, and subsequently produced anti-G in addition to anti-C. The anti-G is considered to have an anti-D cross-reactivity.
Titers of three (anti-E, -Jka, and -S) of the six kinds of clinically important antibodies in the patient's serum were too low to be detected by the regular serological studies madeon admission. As a result, incompatible red blood cells were transfused, and delayed hemolytic transfusion reactions were induced in this patient. Because anti-E was first detected in his serum a few days after the incompatible blood transfusion, this is probably the most offending antibody for the hemolysis (1 1). Both antiJka and anti-S also appear to cause these hemolytic reactions. It is known that most of anti-erythrocyte alloantibodies seen in patients whohave received multiple transfusions are due to the initial 1-10 transfusions (9). Thus, if frequent tests for these antibodies had been performed early in our patient's transfusion treatment, the three antibodies (anti-E, -Jka, and -S) would probably have been noted before the incompatible transfusion.
After the episode of transfusion reactions in the patient, methylprednisolone was given prior to each transfusion in order to prevent further antibody formations and other hemolytic reactions. This treatment was effective in these preventions. However, a fungal infection developed in the lungs, perhaps as a side-effect.
For the difficulty to find red blood cells compatible with the patient in our prefecture only, we requested a supply of them from other large Red Cross Service Centers in eastern Japan. WhenGroup A compatible red blood cells were not available for a long interval, and the patient's anemia progressed, the patient was transfused with washed Group O red blood cells that did not have antigens with which his serumantibodies reacted. Onthe other hand, whenseveral units of compatible red blood cells were available for a short interval, some of them were frozen and stored until they were used. A large amount of platelets was also transfused to the patient. Therefore, we would like to recommend that blood-group typings, including minor blood groups, among the larger population of Rh(D)-negative subjects should be registrated at Red Cross Service centers, and that frozen red blood cells should be used more frequently. Accordingly, when an Rh(D)-negative patient is encountered with multiple alloantibodies, as our patient was, it may be possible to find sufficient units of compatible red blood cells at Red Cross Service centers.
